Sexual dysfunction. F52
Conditions
Interventions
Intervention 1: Intervention group: Participants (32 people) will take one 250 mg probiotic capsule daily at lunch, before or between meals with a full glass of water for eight weeks. Intervention 2:
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Married women aged 40 to 60 years with menstrual irregularity or menopause Having sex at least twice a month Her husband being monogamous Women's sexual function index questionnaire score FSFI<28 in the initial assessment ? A minimum of 12 months and a maximum of 10 years have passed since menopause in menopausal people ? Occurrence of natural menopause in menopausal people and not following hysterectomy surgery or GnRH receptor agonist drugs
Exclusion criteria
Exclusion criteria: Allergy to any of the products containing probiotics Use of any immunosuppressive drugs Use of drugs that affect sexual performance by the person himself or his wife History of hormonal treatment due to sexual dysfunction during the last two weeks Bleeding or spotting after intercourse, vaginal infection Women who use sexual performance enhancing drugs Addiction of spouses to drugs or alcohol The presence of chronic diseases such as heart disease, diabetes, lupus, mental disorders, etc. History of complete hysterectomy Anatomical deformity of the external genitalia History of pelvic chemotherapy and radiotherapy Severe emotional stress during the 3 months before the start of the study Use of phytoestrogens and other herbal medicines Urinary incontinence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average sexual performance score. Timepoint: At the beginning of the study and eight weeks after the start of the intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average quality of life score. Timepoint: At the beginning of the study and eight weeks after the start of the study. Method of measurement: Menopause-Specific Quality of Life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoghayyeh Valizadeh
Tabriz University of Medical Sciences
Outcome results
None listed